9(top 5%)
papers
174(top 5%)
citations
6(top 5%)
h-index
7(top 5%)
g-index
9
all documents
193
doc citations
124
citing journals

Top Articles

#TitleJournalYearCitations
1Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled analysisBreast Cancer Research201380
218F-fluoromisonidazole PET and Activity of Neoadjuvant Nintedanib in Early HER2-Negative Breast Cancer: A Window-of-Opportunity Randomized TrialClinical Cancer Research201732
3Targeted therapy of metastatic breast cancerClinical and Translational Oncology200931
4Current status of anti-angiogenic agents in the treatment of ovarian carcinomaClinical and Translational Oncology200919
5Critically short telomeres and toxicity of chemotherapy in early breast cancerOncotarget201714
6Competing causes of death in patients with locoregionally advanced head and neck cancer treated with concomitant boost radiation plus concurrent weekly cisplatinClinical and Translational Oncology201313
7276O Pooled analysis of patient (pt)-reported quality of life (QOL) in the MONALEESA (ML)-2, -3, and -7 trials of ribociclib (RIB) plus endocrine therapy (ET) to treat hormone receptor–positive, HER2-negative (HR+/HER2−) advanced breast cancer (ABC)Annals of Oncology20204
8Aromatase Inhibitors As Adjuvant Therapy for Breast Cancer: Overall Survival Versus Disease-Free Survival As a Primary End Point in Clinical PracticeJournal of Clinical Oncology20090
9759P Towards personalized medicine in MIBC: Immunohistochemistry-based taxonomical classification and outcome in patients treated with adjuvant chemotherapyAnnals of Oncology20200